English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-beta induced retinal pigmented epithelium degeneration

MPS-Authors
/persons/resource/persons80301

Deussing,  Jan M.
RG Molecular Neurogenetics, Max Planck Institute of Psychiatry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Narendran, S., Pereira, F., Yerramothu, P., Apicella, I., Wang, S.-b., Ambati, K., et al. (2021). Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-beta induced retinal pigmented epithelium degeneration. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 6(1): 149. doi:10.1038/s41392-021-00537-z.


Cite as: https://hdl.handle.net/21.11116/0000-0008-EA9E-F
Abstract
Nonfibrillar amyloid-beta oligomers (A beta Os) are a major component of drusen, the sub-retinal pigmented epithelium (RPE) extracellular deposits characteristic of age-related macular degeneration (AMD), a common cause of global blindness. We report that A beta Os induce RPE degeneration, a clinical hallmark of geographic atrophy (GA), a vision-threatening late stage of AMD that is currently untreatable. We demonstrate that A beta Os induce activation of the NLRP3 inflammasome in the mouse RPE in vivo and that RPE expression of the purinergic ATP receptor P2RX7, an upstream mediator of NLRP3 inflammasome activation, is required for A beta O-induced RPE degeneration. Two classes of small molecule inflammasome inhibitors-nucleoside reverse transcriptase inhibitors (NRTIs) and their antiretrovirally inert modified analog Kamuvudines-both inhibit A beta Os-induced RPE degeneration. These findings crystallize the importance of P2RX7 and NLRP3 in a disease-relevant model of AMD and identify inflammasome inhibitors as potential treatments for GA.